1. From the Department of Epidemiology, Merck Research Laboratories, West Point, Pennsylvania, Section of Clinical Epidemiology, Health Sciences Research and Department of Urology, Mayo Clinic, Rochester, Minnesota, Departments of Epidemiology and Biostatics, University of North Carolina, Chapel Hill, North Carolina, and Section of Urology, University of Michigan and The Michigan Prostate Institute, Ann Arbor, Michigan.